Angela Justice - 17 Nov 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC.

Signature
/s/ Margaret Siegel as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Nov 2022
Net transactions value
$0
Form type
4
Filing time
18 Nov 2022, 15:39:00 UTC
Previous filing
18 Mar 2022
Next filing
05 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TCRR Common Stock 9,693 17 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -16,398 -100% $0.000000* 0 17 Nov 2022 Common Stock 16,398 $14.81 Direct F1, F2
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +5,466 $0.000000 5,466 17 Nov 2022 Common Stock 5,466 Direct F2, F3, F4
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -176,850 -100% $0.000000* 0 17 Nov 2022 Common Stock 176,850 $14.81 Direct F1, F5
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +58,950 $0.000000 58,950 17 Nov 2022 Common Stock 58,950 Direct F3, F4, F5
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -3,791 -100% $0.000000* 0 17 Nov 2022 Common Stock 3,791 $16.10 Direct F6, F7
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +1,264 $0.000000 1,264 17 Nov 2022 Common Stock 1,264 Direct F3, F7, F8
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -7,876 -100% $0.000000* 0 17 Nov 2022 Common Stock 7,876 $16.10 Direct F6, F9
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +2,626 $0.000000 2,626 17 Nov 2022 Common Stock 2,626 Direct F3, F8, F9
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -4,414 -100% $0.000000* 0 17 Nov 2022 Common Stock 4,414 $31.83 Direct F10, F11
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +803 $0.000000 803 17 Nov 2022 Common Stock 803 Direct F3, F11, F12
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -62,586 -100% $0.000000* 0 17 Nov 2022 Common Stock 62,586 $31.83 Direct F10, F13
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +11,380 $0.000000 11,380 17 Nov 2022 Common Stock 11,380 Direct F3, F12, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This cancelled option vested 25% on October 10, 2020 with the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
F2 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on October 10, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 5,466.
F3 Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
F4 79% of these restricted stock units will vest on December 1, 2022 and the remaining 21% will vest on December 1, 2023.
F5 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on October 10, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 58,950.
F6 This cancelled option vested 25% on January 1, 2021 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F7 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 19, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 1,264.
F8 73% of these restricted stock units will vest on December 1, 2022, 25% will vest on December 1, 2023 and the remaining 2% will vest on December 1, 2024.
F9 On November 17, 2022, the issuer cancelled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 19, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 2,626.
F10 This cancelled option vested 25% on January 1, 2022 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F11 On November 17, 2022, the issuer cancelled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 10, 2020. In exchange for such stock option, the reporting person received restricted stock units in the amount of 803.
F12 48% of these restricted stock units will vest on December 1, 2022, 25% will vest on December 1, 2023, 25% will vest on December 1, 2024 and the remaining 2% will vest on December 1, 2025.
F13 On November 17, 2022, the issuer cancelled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 10, 2020. In exchange for such stock option, the reporting person received restricted stock units in the amount of 11,380.